State Licensing Clause Samples

State Licensing. 58.1 When ANAHEIM determines that the duties of a position require a driver license other than the class “C” California driver license, ANAHEIM will provide employees assigned to such positions (a) training in vehicle operation, (b) a vehicle to be used in the testing process, (c) payment of any required medical examination, and (d) payment for the difference in cost between such driver license and a class “C” driver license. 58.2 In the event ANAHEIM assigns employees duties requiring application of pesticides for which possession of a state license becomes required by the state or ANAHEIM, ANAHEIM shall, upon request of AMEA, reopen this Agreement and meet and confer concerning compensation for such required license.
State Licensing. ‌ 57.1 When ANAHEIM determines that the duties of a position require a driver license other than the class “C” California driver license, ANAHEIM will provide employees assigned to such positions: 57.1.1 Required training in vehicle operation: Employees required to successfully complete the Federal Motor Carrier Safety Administration Entry Level Driver Training (hereinafter “ELDT”) program shall be provided training in accordance with the following terms. Those newly hired or promoted into a position triggering this requirement must pass the EDLT and obtain their class “A” or class “B” driver’s license prior to the completion of their probationary period. 57.1.1.1 The ELDT course shall be selected by and paid for by ANAHEIM. 57.1.1.2 ANAHEIM shall retain sole discretion for the timing of scheduling the employee’s ELDT course with consideration given to an employee’s need to complete training and licensing requirement prior to the end of probation. 57.1.1.3 Employees shall be compensated for time completing ELDT course. To the extent possible, such training shall be completed during regularly scheduled work hours. To the extent allowed under the law, employee time spent practicing or studying course material shall be considered non-work time and will not be paid time. 57.1.2 A vehicle to be used in the training and testing process. 57.1.3 Payment of any required medical examination to obtain and maintain required class “A” or class “B” license. 57.1.3.1 Employees have the option of having the Department of Transportation (DOT) medical examination conducted by ANAHEIM’s contracted medical clinic at ANAHEIM’s cost. 57.1.3.1.1 Employees required to undergo such medical examination shall be eligible for up to two (2) hours of paid time off during the employee’s regular work schedule for the purpose of traveling to/from and attending a DOT medical examination. Such time off must be pre- approved by the employee’s supervisor. Additional time spent attending a medical evaluation during the employee’s regular work schedule may be compensated through sick leave should the medical evaluation require more than two (2) hours to complete. Overtime pay will not be approved for any time required for the examination or travel time beyond the two (2) paid leave hours. 57.1.3.1.2 If the medical clinic requires an employee to have a supplemental examination conducted that results in an out-of-pocket cost to the employee, the employee may request reimbursement of such out-of-p...
State Licensing. Argosy University is authorized to offer degree-granting programs in each of the states in which the institution operates a campus. Argosy University, Atlanta is authorized by the Georgia Nonpublic Post-secondary Education Commission (▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇, ▇.▇▇▇.▇▇▇.▇▇▇▇). Argosy University, Chicago and Argosy University, Schaumburg are authorized by the Illinois Board of Higher Education (▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Second Floor, Springfield, IL 62701, ▇.▇▇▇.▇▇▇.▇▇▇▇,▇▇▇.▇▇▇▇.▇▇▇▇▇.▇▇.▇▇/▇▇▇▇▇▇▇.▇▇▇). Argosy University, Dallas is authorized by the Texas Higher Education Coordinating Board (Box 12788, Austin, Texas 78711, ▇.▇▇▇.▇▇▇.▇▇▇▇). Argosy University, Denver campus is regulated by the Colorado Commission on Higher Education (CCHE), ▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇. ▇.▇▇▇.▇▇▇.▇▇▇▇. Argosy University, Inland Empire; Argosy University Los Angeles; Argosy University, Orange County; Argosy University, San Diego; and Argosy University, San Francisco Bay Area were granted approval to operate by the California Bureau for Private Post-secondary and Vocational Education prior to the dissolution of the agency. For information about regulation in California at this time please contact the California Department of Consumer Affairs (▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇-▇▇▇, ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, ▇.▇▇▇.▇▇▇.▇▇▇▇, ▇▇▇.▇▇▇▇▇.▇▇.▇▇▇). Argosy University, Nashville is authorized by the Tennessee Higher Education Commission (Parkway Towers, Suite 1900, ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ Parkway, Nashville, TN 37243, ▇.▇▇▇.▇▇▇.▇▇▇▇). This authorization must be renewed each year and is based on an evaluation by minimum standards concerning quality of education, ethical business practices, health and safety, and fiscal responsibility. Argosy University, Phoenix is authorized by the Arizona State Board for Private Post-secondary Education (▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, ▇.▇▇▇.▇▇▇.▇▇▇▇, ▇▇▇▇://▇▇▇▇▇▇.▇▇▇▇▇.▇▇.▇▇). Argosy University, Salt Lake City is exempt from registration pursuant to the Utah Postsecondary Proprietary School Act. Any questions should be directed to the Utah Division of Consumer Protection (UDCP) (▇▇▇ ▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇▇, Salt Lake City, UT 84114, 801-530-6601). Argosy University, Sarasota and Argosy University, Tampa are licensed by the Commission of Independent Education, Florida Department of Education. Additional information regarding the institutions may be obtained by contacting the Commission ...
State Licensing. Be licensed by the State of Missouri to do business in the State of Missouri; and
State Licensing. The Company shall, prior to the Closing, either (a) withdraw or cause its applicable Subsidiary to withdraw any pending filings or applications for those certain state Permits set forth on Section 5.20 of the Company Disclosure Letter; provided that neither the Company nor any of its Subsidiaries shall be required to withdraw any such application prior to the earlier of the date on which (i) the condition set forth in Section 6.01 is satisfied and (ii) the condition set forth in Section 6.03 is satisfied or (b) if any such filings or applications are approved prior to the time at which the Company or its applicable Subsidiary withdraws such filing or application surrender such Permit such that no approval by or consent from any Governmental Body is required under applicable Law with respect to such Permit.
State Licensing. CONTRACTORS ARE REQUIRED BY LAW TO BE LICENSED AND REGULATED BY THE CONTRACTORS STATE LICENSE BOARD, WHICH HAS JURISDICTION TO INVESTIGATE COMPLAINTS AGAINST CONTRACTORS IF A COMPLAINT REGARDING A PATENT ACT OR OMISSION IS FILED WITHIN FOUR YEARS OF THE DATE OF THE ALLEGED VIOLATION. A COMPLAINT REGARDING A LATENT ACT OR OMISSION PERTAINING TO STRUCTURAL DEFECTS MUST BE FILED WITHIN 10 YEARS OF THE DATE OF THE ALLEGED VIOLATION. ANY QUESTIONS CONCERNING A CONTRACTOR MAY BE REFERRED TO THE REGISTRAR, CONTRACTORS STATE LICENSE BOARD, ▇.▇. ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇.
State Licensing. All personnel shall be licensed and certified, or become licensed and certified within 90 calendar days of beginning employment, to perform work within their normal duties, where such licensing is required by the State for non-Federal locations. Contractor personnel shall also conform to all other licensing and certification requirements as described elsewhere in this document or at the task order level.
State Licensing. Maintain state licenses for the distribution of drug products and medical devices as applicable and fulfil all state reporting obligations.

Related to State Licensing

  • Licensing The Subrecipient, unless otherwise exempted by law, shall obtain and maintain all licenses, permits, and authority necessary to perform those acts it is obligated to perform under this Agreement.

  • Sub-licensing Nuvectis may grant sub-licences (through multiple tiers) of its rights under this Agreement, provided that: (1) the granting of any sub-licences shall not relieve Nuvectis of any obligations or duties imposed on it under this Agreement; (2) it shall not grant or allow the grant of any sub-licences to (i) a tobacco company (being any entity identified as such in the Cancer Research UK Code of Practice on Tobacco Industry Funding to Universities); or (ii) a party which is actively and/or currently engaged in the manufacture, production or sale of weapons or ammunition; (3) subject to the provisions of Clause 2.5, such sub-licence shall be on arm’s length commercial terms reflecting the market value of the rights granted; (4) [***]; (5) [***]; (6) Nuvectis shall ensure that there are included in any sub-licence terms which shall enable Nuvectis to comply with its obligations under this Agreement; (7) subject to the provisions of clause 12.6, each sub-licence shall, and shall be expressed in each sub-licence agreement to, terminate automatically upon termination of the license under clause 2.1 and/or any commercial licence to the Collaboration Option IP; (8) [***]; (9) it shall diligently collect all amounts due under each sub-licence; (10) Nuvectis shall ensure that each Sub-Licence does not prohibit Nuvectis’s grant and the implementation of any [***] hereunder; (11) it shall be responsible for any breach of the sub-licence by the Sub-Licensee of Licensed Products and/or Additional Licensed Products, as if the breach had been that of Nuvectis under this Agreement; (12) the grant of any sub-licence shall be without prejudice to Nuvectis’s obligations under this Agreement. Any act or omission of any Sub-Licensee which, if it were the act or omission of Nuvectis would be a breach of any of the provisions of this Agreement, will be deemed to be a breach of this Agreement by Nuvectis who will be liable to the University accordingly; (13) the obligations in Clause 2.4 (3), (4), (5), (6) (excluding the development and commercialisation obligations set out in Clause 5.1), (8) and (9) shall not apply in relation to agreements that Nuvectis and/or a Sub-Licensee enters into with Third Party Service Providers, provided that: (a) such agreements relate to the provision of research, development and/or manufacturing services to Nuvectis and/or a Sub-Licensee in connection with Licensed Products and/or Additional Licensed Products; and (b) no rights are granted to such Third Party Service Providers to: (i) research, develop or manufacture its own products; and/or (ii) sell the Licensed Products and/or Additional Licensed Products; (14) each subclause of this Clause 2.4 shall apply to each tier of sub-licence unless expressly stated otherwise.

  • Sublicensing Licensee has the right to grant Sublicense Agreements under the Licensed Subject Matter consistent with the terms of the Agreement, subject to the following: (a) A Sublicense Agreement shall not exceed the scope and rights granted to Licensee hereunder. Sublicensee must agree in writing to be bound by the applicable terms and conditions of the Agreement and shall indicate that Licensor is a third party beneficiary of the Sublicense Agreement. In the event of termination of this Agreement, continued sublicense rights shall be governed by Section 7.5(a) (Effect of Termination). Licensee has no right to grant a Sublicensee the right to grant further sub-Sublicense Agreements. (b) Licensee shall deliver to Licensor a true, complete, and correct copy of each Sublicense Agreement granted by Licensee, Affiliate or Sublicensee, and any modification or termination thereof, within thirty (30) days following the applicable execution, modification, or termination of such Sublicense Agreement. All Sublicense Agreements will be in English. (c) Notwithstanding any such Sublicense Agreement, Licensee will remain primarily liable to Licensor for all of the Licensee’s duties and obligations contained in the Agreement, including without limitation the payment of running royalties due under Section 3.2 whether or not paid to Licensee by a Sublicensee. Any act or omission of a Sublicensee that would be a breach of the Agreement if performed by Licensee will be deemed to be a breach by Licensee. Each Sublicense Agreement will contain a right of termination by Licensee in the event that the Sublicensee breaches the payment or reporting obligations affecting Licensor or any other terms and conditions of the Sublicense Agreement that would constitute a breach of the Agreement if such acts were performed by Licensee.